Anemia can both mimic and genuinely worsen the symptoms of postural orthostatic tachycardia syndrome. The overlap is so significant that a recent JAMA review lists anemia among the conditions clinicians should actively exclude before confirming a POTS diagnosis. The connection runs deeper than surface-level symptom similarity, though, touching on blood volume, autonomic nerve signaling, and blood vessel behavior in ways that make the two conditions feed off each other when they coexist.
How Anemia Drives a Faster Heart Rate on Standing
The hallmark of POTS is an excessive rise in heart rate when you stand up, usually at least 30 beats per minute within ten minutes of going upright. Anemia produces its own version of this problem through a straightforward chain of events. When your red blood cell count drops, each unit of blood carries less oxygen. Your body detects this shortfall through specialized oxygen sensors, and the response is predictable: the sympathetic nervous system ramps up, pumping out more adrenaline-like chemicals to push the heart faster and harder.
Research on the cardiovascular effects of anemia has confirmed that heart rate rises because hypoxia-stimulated chemoreceptors trigger increased sympathetic activity, and the heart contracts more forcefully due to elevated catecholamine levels and other stimulatory signals. If you already have POTS, that extra sympathetic push lands on top of an autonomic system that is already overreacting to gravity. The result is a compounding effect: standing becomes even more taxing, dizziness worsens, and the heart races more than it would from either condition alone.
A study on iron deficiency anemia specifically found evidence of altered autonomic nervous system activity, with researchers proposing a direct link between anemia and accentuated sympathetic drive triggered by the oxygen deficit sensed through the carotid bodies in the neck. This matters because many POTS patients already fall into a “hyperadrenergic” subtype where excessive sympathetic activation is the core problem. Adding anemia to that mix is like turning up the volume on a speaker that is already too loud.
The Blood Volume Problem
One of the most consistent findings in POTS research is that patients tend to have lower-than-expected blood volume. A 2024 study using carbon monoxide rebreathing to measure blood volume found that POTS patients had meaningfully lower red blood cell volume compared to healthy women, along with total blood volume deficits averaging about 14% below expected levels. The researchers also found a clear correlation: the bigger the blood volume deficit, the faster the heart rate climbed on standing.
This is where anemia connects to POTS at a structural level. Anemia, by definition, means fewer red blood cells or less hemoglobin circulating in your blood. That directly reduces both red blood cell volume and total blood volume. Earlier work on patients with chronic fatigue syndrome, a condition that frequently overlaps with POTS, found that subnormal circulating red blood cell volume and orthostatic tachycardia were very common findings and may be involved in causing symptoms. When you have less blood to work with, gravity pulls a larger fraction of it into your legs on standing, leaving less for your brain and heart. The compensatory heart rate spike is the body’s attempt to keep blood flowing upward, and it often falls short.
A separate study used acute saline infusion to test this directly. POTS patients started with blood volume deficits averaging about 13% below ideal. After receiving intravenous saline, their stroke volume rose significantly and cardiac output improved, demonstrating that simply restoring volume made the cardiovascular system work more efficiently. This suggests that anything reducing blood volume, including anemia, worsens the fundamental hemodynamic problem in POTS.
Iron Deficiency Without Full-Blown Anemia
You do not need to be formally anemic for low iron to make your POTS worse. A study of adolescents with POTS found that half had low iron storage, compared to about 14% in the general pediatric population. Iron deficiency, where stores are depleted but hemoglobin has not yet dropped enough to meet the technical definition of anemia, was also dramatically more common in POTS patients. Among teenage girls with POTS, about a quarter were iron deficient compared to 9% of the general population. Among teenage boys, the gap was even more striking: 16% versus 1%.
This matters because iron does more in the body than just help make red blood cells. Iron is a building block for enzymes involved in energy production, neurotransmitter synthesis, and oxygen transport at the tissue level. When iron stores are low, you can experience fatigue, brain fog, exercise intolerance, and lightheadedness even before your blood count drops into the anemia range. Those symptoms are nearly identical to POTS symptoms, which makes it easy for iron deficiency to go unnoticed in someone who already has a POTS diagnosis. A separate tertiary care study of pediatric POTS patients confirmed that insufficient iron stores were commonly seen alongside the condition.
A review in Frontiers in Pediatrics identified iron insufficiency as one of several pathophysiologic factors in POTS among children and adolescents, listing it alongside abnormal autonomic reflexes, reduced central blood volume, and other mechanisms. The fact that iron deficiency appears on that list even without meeting the threshold for anemia underscores how sensitive the autonomic nervous system is to iron status.
How Iron Deficiency Changes Blood Vessel Behavior
Beyond the oxygen-carrying issue, iron deficiency anemia alters how blood vessels regulate their own tone. Research in animal models found that iron deficiency anemia caused a marked increase in nitric oxide production throughout the body, including in the aorta and kidneys. Nitric oxide is a powerful vasodilator, meaning it relaxes blood vessel walls and allows them to widen. The study found increased expression of the enzymes that produce nitric oxide, and the degree of increase was directly related to how severe the anemia was.
In POTS, excessive pooling of blood in the legs and abdomen on standing is already a central problem. If iron deficiency is simultaneously ramping up nitric oxide and encouraging blood vessels to relax and widen, the pooling gets worse. More blood drops into the lower body, less reaches the brain, and the heart has to work even harder to compensate. This vascular mechanism may help explain why some POTS patients feel dramatically worse when their iron levels dip, even if the change in hemoglobin looks modest on paper.
Anemia as a Diagnostic Confounder
One of the practical challenges with anemia and POTS is that they can look nearly identical on a tilt table test. Both conditions produce a fast heart rate on standing. Both cause lightheadedness, fatigue, and sometimes near-fainting. A 2025 JAMA review of POTS explicitly states that the initial evaluation should exclude conditions that cause sinus tachycardia, listing anemia alongside thyroid disease, adrenal insufficiency, dehydration, and medication effects.
This is not just a technicality. If a clinician diagnoses POTS without checking iron studies and a complete blood count, they may miss a treatable cause of the symptoms entirely. Moderate anemia alone can produce an exaggerated heart rate response that meets the numerical criteria for POTS. Treating the anemia in that scenario could resolve the tachycardia completely, sparing the patient from unnecessary medications or lifestyle restrictions aimed at a condition they do not actually have.
On the flip side, if someone does have genuine POTS and also happens to be anemic, treating only the POTS while ignoring the anemia means you are fighting the symptoms with one hand tied behind your back. The anemia will keep driving the heart rate up, reducing blood volume, and promoting vasodilation, counteracting whatever medications or salt-loading strategies are being used to manage the POTS itself.
Menstruation, Blood Loss, and Symptom Flares
POTS disproportionately affects women of reproductive age, and menstrual blood loss creates a recurring opportunity for iron depletion. Research comparing POTS patients with healthy controls found that patients with POTS reported increased lightheadedness throughout all phases of the menstrual cycle, but both groups experienced the worst lightheadedness during menses. POTS patients also reported a higher rate of gynecologic conditions overall.
The practical implication is that heavy periods can create a cyclical worsening pattern. Each menstrual cycle strips away some iron. If intake or absorption does not keep pace, iron stores gradually decline over months, and POTS symptoms worsen in a slow creep that is easy to attribute to stress or deconditioning rather than a correctable nutritional deficit. Women with POTS who notice their symptoms are worst around their period, or who see a gradual worsening over time without an obvious trigger, should consider whether iron depletion is part of the picture.
Does Treating Iron Deficiency Actually Improve POTS Symptoms?
The evidence here is still emerging, but what exists is encouraging. An early-phase clinical trial using intravenous iron for POTS patients found that about two-thirds of participants experienced a reduction in their symptoms. That is a meaningful response rate for a condition that often resists treatment, though it is worth noting this was an early trial and not the kind of large, controlled study that provides definitive answers.
The logic behind the intervention is sound based on everything discussed so far. If low iron is reducing blood volume, driving up sympathetic activity, and promoting excess vasodilation, then restoring iron should reverse at least some of those effects. Intravenous iron is used in the trial setting because it bypasses the gut and restores stores quickly, but oral iron supplementation is the more common real-world approach. Oral iron is slower and can cause gastrointestinal side effects, but it works for most people if the deficiency is not severe.
It is worth being realistic about expectations. Iron repletion is unlikely to cure POTS on its own, since the condition involves multiple interacting mechanisms. But correcting a deficiency removes one contributor to the symptom burden, which can make the difference between a manageable day and a debilitating one. For patients who have been told “your labs are normal” based on a hemoglobin level alone, it is worth asking specifically about ferritin, which reflects iron stores and can be low well before hemoglobin drops.
What Labs to Ask For
A standard complete blood count will catch anemia if it is present, but it will not catch iron deficiency in its earlier stages. The key test is serum ferritin, which reflects how much iron your body has in reserve. A ferritin level can be bottomed out while hemoglobin remains in the normal range, meaning you could be profoundly iron-depleted without being technically anemic. Many clinicians use a ferritin cutoff of 30 or even 50 micrograms per liter as the threshold below which symptoms can appear, even though the “normal” range printed on lab reports often starts much lower.
Other useful markers include transferrin saturation and sometimes soluble transferrin receptor, which help distinguish iron deficiency from other causes of low ferritin like inflammation. For POTS patients who have been through the diagnostic wringer and are still struggling, a full iron panel is a relatively simple, inexpensive test that can reveal a treatable contributor. Given that research consistently shows iron deficiency and low iron stores are far more common in POTS patients than in the general population, this is not a fishing expedition. It is a targeted check for a known association.
A Historical Echo
The connection between iron deficiency and cardiovascular symptoms in young women is not a modern discovery, even if the POTS label is relatively new. A condition called chlorosis, first described in the 16th century, was an anemia found predominantly in adolescent girls and young women. Despite a 17th-century recommendation to treat it with iron supplements, chlorosis was classified for centuries among the “hysterical diseases.” It was not until the late 1800s that a researcher proposed it was simply nutritional iron deficiency, and even that view was largely ignored for decades.
The parallels to POTS are hard to miss. POTS predominantly affects young women, is frequently dismissed or misdiagnosed, and has only recently gained mainstream medical recognition. Some historians of medicine have speculated that many cases described as chlorosis, with their fainting, fatigue, rapid heartbeat, and exercise intolerance, may have been what we would now recognize as iron-deficient POTS patients. Whether or not that speculation holds up, the historical pattern of dismissing cardiovascular symptoms in young women as psychological rather than investigating treatable causes like iron deficiency is a cautionary tale that resonates uncomfortably with the experiences many POTS patients report today.